Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Tryptamine Therapeutics Ltd Appoints Hamish George As Chief Financial Officer

PRIVATESep 03, 2024•almost 2 years ago

Position

Chief Financial Officer

Company

Tryptamine Therapeutics

Hamish George
MelbourneBiotechnologyHealth Care

Description

Tryptamine Therapeutics Ltd has appointed finance and commercial expert Hamish George as chief financial officer (CFO), effective September 1, 2024. The company looks forward to leveraging George’s expertise as it advances its extensive clinical trial pathway utilizing TRP-8802 and TRP-8803.

Company Information

Company

Tryptamine Therapeutics

Location

Melbourne, Victoria, Australia

About

Tryptamine Therapeutics Ltd is a clinical-stage biotechnology company focused on drug development in the biotechnology and healthcare sector. The company is listed on the Australian Securities Exchange (ASX:TYP, OTC:TYPTF) and is actively involved in extensive clinical trials utilizing TRP-8802 (oral psilocybin) and TRP-8803 (IV-infused psilocin).

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Tryptamine Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.